RxDoctor Payments Data

Marcos Carvajal Bermejo

Psychiatric/Mental Health · Miami Lakes, FLNPI 1578223590

Payments from drug & device makers

$4,171in general payments, 2019–2025

Across 203 payments — averaging $20.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Otsuka America Pharmaceutical, Inc.$775
  • Teva Pharmaceuticals USA, Inc.$693
  • Alkermes, Inc.$414
  • Indivior Inc.$291
  • Johnson & Johnson$208
  • plus $536 from 9 others

What the payments were for

  • Food & beverage$4,171100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,171 in reported general payments places this provider in the 85th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate28$212,112
Abilify MaintenaAripiprazole18$41,745
Aripiprazole104$6,685
TrintellixVortioxetine Hydrobromide13$6,165
Quetiapine Fumarate312$3,171
Duloxetine Hcl168$3,114
Clozapine21$2,229
Buspirone Hcl261$1,894
Mirtazapine201$1,750
Memantine Hcl112$1,533
Clonazepam252$1,494
Trazodone Hcl267$1,401
Olanzapine73$1,355
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl13$1,143
Alprazolam168$1,053

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$86$212,11228 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$775$41,74518 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$41$6,16513 claims
Almatica Pharma LLCSertraline Hcl$27$571171 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,096 psychiatric/mental health providers in Florida.

Other psychiatric/mental health in Miami Lakes

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →